Select
ID
Name
Description
1966
Recipient Details - Follow-up Centre
Text
1967
Recipient Details - Centre code
Format: string up to 6 characters
1968
Recipient Details - ODT Recipient number
Format: string up to 6 characters
1969
Recipient Details - ODT Transplant ID
Format: string up to 6 characters
1970
Recipient Details - Hospital number
Text
1971
Transfer and non-attendance - The patient has transferred to another unit for follow-up
Categories: 1 - If yes, please supply full details of unit now caring for this patient in the box below. Please include date of last contact with the patient. 2 - If you are able to make a final follow-up return, please complete and return this form.
1972
Transfer and non-attendance - The patient has not attended for this follow-up but is expected to attend for future follow-up. Complete section 7 and return this form
Categories: 1 - No 2 - Yes
1973
Transfer and non-attendance - The patient is considered lost to follow-up. Further contact with the patient is not expected
Categories: 1 - Please supply the reason for loss to all further follow-up in the box below 2 - Please include the date of the last contact with the patient 3 - If you are able to make a final follow-up return please complete and return this form
1974
Transfer and non-attendance - Follow-up details - Further details
Text
1975
Transfer and non-attendance - Follow-up details - Date of last contact with the patient (If exact date cannot be established a partial date, for example month and year will be accepted)
Format: DD/MM/YYYY
1976
Post-operative course - Number of treated pancreas rejection episodes in the last 12 months (0 = no rejection)
Format: number
1977
Post-operative course - For first annual assessment only, please enter date of first episode after this transplant
Format: DD/MM/YYYY
1978
Post-operative course - Employment status (`Replace `work` with `study` for recipients in full time education)
Categories: 11 - Working - full time 12 - Able to work - chooses not to 13 - Able to work - unable to find work 14 - Working part time - by choice 15 - Working part time - due to disease 16 - Unable to work - due to disease 17 - Hospitalised 18 - Other 19 - Unknown If code 18 (Other), then can be additionally specified in a separate field
1979
Post-operative course - Employment status (`Replace `work` with `study` for recipients in full time education) - Other
Text
1980
Post-operative course - Smoking - Pipe / Cigars
Categories: 1 - No 2 - Yes
1981
Post-operative course - Smoking - Cigarettes
Categories: 1 - No 2 - Yes 3 - Ex
1982
Post-operative course - Smoking - If YES, no./day (Cigarettes)
Format: string up to 2 characters
1983
Post-operative course - Smoking - If Ex, years since stop (To nearest years, 6 months = 1 year)
Format: string up to 2 characters
1984
Post-operative course - Has this recipient developed evidence of a primary or recurrent disease in the islet graft during the past 12 months?
Categories: 1 - No 2 - Yes
1985
Post-operative - Malignancy details - Has the recipient developed post-transplant lymphoproliferative disease (PTLD) or lymphoma in the 12 months?
Categories: 1 - No 2 - Yes
1986
Post-operative - Malignancy details - Has the recipient developed a malignancy in the 12 months (excluding PTLD, lymphoma and cervical dysplasia)?
Categories: 1 - No 2 - Yes If YES futher details will be provided
1987
Post-operative - Malignancy details - Type of malignancy (malignancy #1)
Format: Text
1988
Post-operative - Malignancy details - ICD10 code (malignancy #1)
Format: string up to 4 characters
1989
Post-operative - Malignancy details - Date first diagnosed (malignancy #1)
Format: DD/MM/YYYY
1990
Post-operative - Malignancy details - Could the malignancy be of donor origin? (malignancy #1)
Categories: 1 - No evidence 2 - Yes - very likely 3 - Yes - possibly
1991
Post-operative - Malignancy details - Type of malignancy (malignancy #2)
Format: Text
1992
Post-operative - Malignancy details - ICD10 code (malignancy #2)
Format: string up to 4 characters
1993
Post-operative - Malignancy details - Date first diagnosed (malignancy #2)
Format: DD/MM/YYYY
1994
Post-operative - Malignancy details - Could the malignancy be of donor origin? (malignancy #2)
Categories: 1 - No evidence 2 - Yes - very likely 3 - Yes - possibly
1995
Post-operative - Malignancy details - Type of malignancy (malignancy #3)
Format: Text
1996
Post-operative - Malignancy details - ICD10 code (malignancy #3)
Format: string up to 4 characters
1997
Post-operative - Malignancy details - Date first diagnosed (malignancy #3)
Format: DD/MM/YYYY
1998
Post-operative - Malignancy details - Could the malignancy be of donor origin? (malignancy #3)
Categories: 1 - No evidence 2 - Yes - very likely 3 - Yes - possibly
1999
Graft and recipient status - Has the pancreatic islet graft failed? (C-peptide<50pmol/l) (Recipient died with a functioning graft, please record as failed with reason 90, death with functioning graft)
Categories: 1 - No 2 - Yes If YES futher details will be provided
2000
Graft and recipient status - Date of failure (date C-peptide recorded below 50pmol/l)
Format: DD/MM/YYYY
2001
Graft and recipient status - Cause of failure
Categories: 1 - Vascular thrombosis 2 - Infection 3 - Bleeding 6 - Primary non-function (no detectable C-peptide between 7 and 28 days) 7 - Patient declined medication 8 - Hyperacute rejection 9 - Acute rejection 10 - Chronic rejection 11 - Preservation / Procurement problem 12 - Instant blood mediated inflammatory reaction (IBMIR) 13 - Poor engraftment 14 - Functional decline (unknown cause) 15 - Recurrent autoimmunity 16 - Hepatitis / Steatosis 17 - Cholangitis 90 - Death with a functioning graft 98 - Other 99 - Unknown If "Cause of failure" code is Other identified cause of death (98), then can be additionally specified in a separate field
2002
Graft and recipient status - Other identified cause of failure
Text
2003
Graft and recipient status - Has the recipient died?
Categories: 1 - No 2 - Yes If YES futher details will be provided
2004
Graft and recipient status - Date of death
Format: DD/MM/YYYY
2005
Graft and recipient status - Cause of death - Primary
Categories: 11 - Cardiothoracic - Myocardial ischaemia and infarction 12 - Cardiothoracic - Hyperkalaemia 13 - Cardiothoracic - Haemorrhagic pericarditis 15 - Cardiothoracic - Sudden unexplained cardiac death 16 - Cardiothoracic - Hypertensive cardiac failure 17 - Cardiothoracic - Hypokalaemia 18 - Cardiothoracic - Fluid overload 19 - Cardiothoracic - Elevated PVR/Pulmonary hypertension 20 - Cardiothoracic - Airway dehiscence 75 - Cardiothoracic - Early graft dysfunction 76 - Cardiothoracic - Cardiac tamponade 14 - Cardiothoracic - Other causes of cardiac failure 77 - Cardiothoracic - ARDS 78 - Cardiothoracic - Respiratory failure 21 - Vascular - Pulmonary embolus 22 - Vascular - Cerebro-vascular accident 24 - Vascular - Haemorrhage from graft site 25 - Vascular - Haemorrhage from vascular access or dialysis circuit 26 - Vascular - Haemorrhage from ruptured vascular aneurysm (not Code 22 or 23) 27 - Vascular - Haemorrhage from surgery (not Codes 23, 24 or 26) 28 - Vascular - Other haemorrhage (not Codes 23-27) 30 - Infection - Pulmonary infection (protozoal) 31 - Infection - Pulmonary infection (bacterial) 32 - Infection - Pulmonary infection (viral) 33 - Infection - Pulmonary infection (fungal) 34 - Infection - Infections elsewhere (except viral hepatitis see Code 41 and 42) 35 - Infection - Septicaemia 36 - Infection - Tuberculosis (lung) 37 - Infection - Tuberculosis (elsewhere) 38 - Infection - Generalized viral infection 39 - Infection - Peritonitis (not Code 70) 41 - Liver disease - Liver, due to hepatitis B virus 42 - Liver disease - Liver, other viral hepatitis 43 - Liver disease - Liver, drug toxicity 44 - Liver disease - Cirrhosis, not viral 45 - Liver disease - Cystic liver disease 46 - Liver disease - Liver failure, cause unknown 23 - Gastro-intestinal - Gastro-intestinal haemorrhage 29 - Gastro-intestinal - Mesenteric infarction 62 - Gastro-intestinal - Pancreatitis 70 - Gastro-intestinal - Sclerosing (or adhesive) peritoneal disease 71 - Gastro-intestinal - Perforation of peptic ulcer 72 - Gastro-intestinal - Perforation of colon 51 - Social - Patient refused further treatment 52 - Social - Suicide 53 - Social - Therapy ceased for any other reason 47 - Miscellaneous - Renal failure 48 - Miscellaneous - Recurrent primary disease, benign 49 - Miscellaneous - Recurrent primary disease, malignant 61 - Miscellaneous - Uraemia caused by graft failure 63 - Miscellaneous - Bone marrow depression 64 - Miscellaneous - Cachexia 66 - Miscellaneous - Lymphoid malignant disease possibly induced by immunosuppressive therapy 67 - Miscellaneous - Lymphoid malignant disease not induced by immunosuppressive therapy 69 - Miscellaneous - Dementia 73 - Miscellaneous - Non-lymphoid malignant disease possibly induced by immunosuppressive therapy 74 - Miscellaneous - Non-lymphoid malignant disease not induced by immunosuppressive therapy 79 - Miscellaneous - Multi-system failure 81 - Accident - Accident related to treatment 82 - Accident - Accident unrelated to treatment 90 - Donor organ failure 98 - Other identified cause of death 99 - Unknown If "Cause of death" code is Other identified cause of death (98), then can be additionally specified in a separate field
2006
Graft and recipient status - Cause of death - Primary - Other identified cause of death
Text
2007
Graft and recipient status - Cause of death - Secondary
Categories: 11 - Cardiothoracic - Myocardial ischaemia and infarction 12 - Cardiothoracic - Hyperkalaemia 13 - Cardiothoracic - Haemorrhagic pericarditis 15 - Cardiothoracic - Sudden unexplained cardiac death 16 - Cardiothoracic - Hypertensive cardiac failure 17 - Cardiothoracic - Hypokalaemia 18 - Cardiothoracic - Fluid overload 19 - Cardiothoracic - Elevated PVR/Pulmonary hypertension 20 - Cardiothoracic - Airway dehiscence 75 - Cardiothoracic - Early graft dysfunction 76 - Cardiothoracic - Cardiac tamponade 14 - Cardiothoracic - Other causes of cardiac failure 77 - Cardiothoracic - ARDS 78 - Cardiothoracic - Respiratory failure 21 - Vascular - Pulmonary embolus 22 - Vascular - Cerebro-vascular accident 24 - Vascular - Haemorrhage from graft site 25 - Vascular - Haemorrhage from vascular access or dialysis circuit 26 - Vascular - Haemorrhage from ruptured vascular aneurysm (not Code 22 or 23) 27 - Vascular - Haemorrhage from surgery (not Codes 23, 24 or 26) 28 - Vascular - Other haemorrhage (not Codes 23-27) 30 - Infection - Pulmonary infection (protozoal) 31 - Infection - Pulmonary infection (bacterial) 32 - Infection - Pulmonary infection (viral) 33 - Infection - Pulmonary infection (fungal) 34 - Infection - Infections elsewhere (except viral hepatitis see Code 41 and 42) 35 - Infection - Septicaemia 36 - Infection - Tuberculosis (lung) 37 - Infection - Tuberculosis (elsewhere) 38 - Infection - Generalized viral infection 39 - Infection - Peritonitis (not Code 70) 41 - Liver disease - Liver, due to hepatitis B virus 42 - Liver disease - Liver, other viral hepatitis 43 - Liver disease - Liver, drug toxicity 44 - Liver disease - Cirrhosis, not viral 45 - Liver disease - Cystic liver disease 46 - Liver disease - Liver failure, cause unknown 23 - Gastro-intestinal - Gastro-intestinal haemorrhage 29 - Gastro-intestinal - Mesenteric infarction 62 - Gastro-intestinal - Pancreatitis 70 - Gastro-intestinal - Sclerosing (or adhesive) peritoneal disease 71 - Gastro-intestinal - Perforation of peptic ulcer 72 - Gastro-intestinal - Perforation of colon 51 - Social - Patient refused further treatment 52 - Social - Suicide 53 - Social - Therapy ceased for any other reason 47 - Miscellaneous - Renal failure 48 - Miscellaneous - Recurrent primary disease, benign 49 - Miscellaneous - Recurrent primary disease, malignant 61 - Miscellaneous - Uraemia caused by graft failure 63 - Miscellaneous - Bone marrow depression 64 - Miscellaneous - Cachexia 66 - Miscellaneous - Lymphoid malignant disease possibly induced by immunosuppressive therapy 67 - Miscellaneous - Lymphoid malignant disease not induced by immunosuppressive therapy 69 - Miscellaneous - Dementia 73 - Miscellaneous - Non-lymphoid malignant disease possibly induced by immunosuppressive therapy 74 - Miscellaneous - Non-lymphoid malignant disease not induced by immunosuppressive therapy 79 - Miscellaneous - Multi-system failure 81 - Accident - Accident related to treatment 82 - Accident - Accident unrelated to treatment 90 - Donor organ failure 98 - Other identified cause of death 99 - Unknown If "Cause of death" code is Other identified cause of death (98), then can be additionally specified in a separate field
2008
Graft and recipient status - Cause of death - Secondary - Other identified cause of death
Text
2009
Post-transplant complications - Total number of days as inpatient during the last 12 months (Excluding transplant admission)
Format: string up to 3 characters
2010
Post-transplant complications - Number of readmissions over the last 12 months (0 = No readmissions)
Format: string up to 2 characters
2011
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Number of severe hypoglycaemia events
Format: string up to 2 characters
2012
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - If one or more, date of first event
Format: DD/MM/YYYY
2013
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Number of admissions with diabetic ketoacidosis
Format: string up to 2 characters
2014
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - If one or more, date of first admission
Format: DD/MM/YYYY
2015
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Angina
Categories: 1 - No 2 - Yes
2016
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Myocardial infarction
Categories: 1 - No 2 - Yes
2017
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - PCI
Categories: 1 - No 2 - Yes 3 - Stent
2018
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Coronary artery bypass graft
Categories: 1 - No 2 - Yes
2019
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Transient ischemic attack
Categories: 1 - No 2 - Yes
2020
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - CVA
Categories: 1 - No 2 - Yes
2021
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Intermittent claudication
Categories: 1 - No 2 - Yes
2022
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - PVD intervention
Categories: 1 - None 2 - Angioplasty 3 - Bypass graft
2023
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Foot ulceration
Categories: 1 - No 2 - Yes 3 - Current
2024
Post-transplant complications - Diabetic complications (Please indicate complications that have occurred during the last 12 months post-transplant, last 6 months for first annual assessment) - Limb amputation
Categories: 1 - No amputation 2 - Major limb amputation 3 - Digital amputation
2025
Post-transplant complications - Diabetic eye disease - Diabetic retinopathy confirmed by dilated digital photography
Categories: 1 - No 2 - Yes
2026
Post-transplant complications - Diabetic eye disease - Registered blind
Categories: 1 - No 2 - Yes - blind 3 - Yes - impaired
2027
Post-transplant complications - Diabetic eye disease - Laser photocoagulation
Categories: 1 - No 2 - Yes
2028
Post-transplant complications - Diabetic eye disease - Cataract
Categories: 1 - No 2 - Yes 3 - Extraction
2029
Post-transplant complications - Diabetic eye disease - Vitreous haemorrhage
Categories: 1 - No 2 - Yes
2030
Post-transplant complications - Diabetic eye disease - Vitrectomy
Categories: 1 - No 2 - Yes
2031
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Proteinuria
Categories: 1 - No 2 - Microalbuminuria 3 - Macroalbuminuria
2032
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Ulceration
Categories: 1 - No 2 - Yes
2033
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Postural hypotension
Categories: 1 - No 2 - Yes
2034
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Erectile/sexual dysfunction
Categories: 1 - No 2 - Yes
2035
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Peripheral neuropathy
Categories: 1 - No 2 - Yes
2036
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Gastroparesis
Categories: 1 - No 2 - Yes
2037
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Autonomic sweating
Categories: 1 - No 2 - Yes
2038
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Charcot foot
Categories: 1 - No 2 - Yes
2039
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Neuropathic pain score (0-10, 0 = no pain)
Format: number
2040
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Diabetic enteropathy
Categories: 1 - No 2 - Yes
2041
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Autonomic bladder dysfunction
Categories: 1 - No 2 - Yes
2042
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Cheiroarthropathy
Categories: 1 - No 2 - Yes
2043
Post-transplant complications - Nephropathy / neuropathy / musculoskeletal (record current status) - Mononeuropathy
Categories: 1 - No 2 - Yes
2044
Post-transplant complications - Other autoimmune disease - Thyroid disease
Categories: 1 - No 2 - Yes
2045
Post-transplant complications - Other autoimmune disease - Addison`s disease
Categories: 1 - No 2 - Yes
2046
Post-transplant complications - Other autoimmune disease - Coeliac disease
Categories: 1 - No 2 - Yes
2047
Post-transplant complications - Other complications - Has the recipient required readmission due to complications?
Categories: 1 - No 2 - Yes If YES, please indicate the complications present
2048
Post-transplant complications - Other complications - Portal vein / hepatic haemorrhage
Categories: 1 - No 2 - Yes
2049
Post-transplant complications - Other complications - Portal vein thrombosis
Categories: 1 - No 2 - Yes
2050
Post-transplant complications - Other complications - Perforated gall bladder
Categories: 1 - No 2 - Yes
2051
Post-transplant complications - Other complications - CMV infection
Categories: 1 - No 2 - Yes
2052
Post-transplant complications - Other complications - Viral systemic infection
Categories: 1 - No 2 - Yes
2053
Post-transplant complications - Other complications - Other
Categories: 1 - No 2 - Yes
2054
Post-transplant complications to 6 months (or graft failure if earlier than 6 months) Other complications - Urinary tract infection (UTI) - Other
Categories: 1 - No 2 - Yes
2055
Post-transplant complications - Other complications - Bacterial systemic infection
Categories: 1 - No 2 - Yes
2056
Post-transplant complications - Other complications - Intraperitoneal abscess
Categories: 1 - No 2 - Yes
2057
Post-transplant complications - Other complications - Fungal systemic infection
Categories: 1 - No 2 - Yes
2058
Post-transplant complications - Other complications - Number of laparotomies performed since transplant? (No laparotomies = 0)
Format: number
2059
Post-transplant complications - Other complications - Futher details of above complications
Text
2060
Post-transplant complications - Other complications - Has the recipient become registered blind in the last 12 months?
Categories: 1 - No 2 - Yes
2061
Post-transplant complications - Visual acuity - Right Eye (6/6, 6/9, 6/12 etc., CF for counting fingers, HM for hand movements at 1 metre, LP for light perception, NP for no light perception)
Format: string up to 3 characters
2062
Post-transplant complications - Visual acuity - Left Eye (6/6, 6/9, 6/12 etc., CF for counting fingers, HM for hand movements at 1 metre, LP for light perception, NP for no light perception)
Format: string up to 3 characters
2063
Clinical assessment - Date of clinical assessment of functioning graft (For grafts still functioning, please report an assessment undertaken no earlier than 11 months post-transplant)
Format: DD/MM/YYYY
2064
Clinical assessment - Has the recipient been insulin independent in the last 12 months (Last 6 months for first annual assessment)?
Categories: 1 - No 2 - Yes
2065
Clinical assessment - Current graft function
Categories: 1 - Insulin independent 2 - Partial function 3 - No function
2066
Clinical assessment - IFCC-HbA1c (units: mmol/mol)
Format: string up to 3 characters
2067
Clinical assessment - Date insulin ceased (If currently insulin independent)
Format: DD/MM/YYYY
2068
Clinical assessment - Current insulin dose (If currently partial or no function) (units: unit/24hr)
Format: string up to 3 characters
2069
Clinical assessment - Date insulin resumed (If previously insulin independent at any time since transplant)
Format: DD/MM/YYYY
2070
Clinical assessment - Glucose lowering drug (For combination treatment only, please enter Drug 1 and Drug 2) - Drug 1
Categories: 0 - None 1 - Metformin 2 - Pioglitazone 3 - Rosi 4 - GLP1 5 - SU 6 - DPPIV 7 - Other
2071
Clinical assessment - Glucose lowering drug (For combination treatment only, please enter Drug 1 and Drug 2) - Drug 2
Categories: 0 - None 1 - Metformin 2 - Pioglitazone 3 - Rosi 4 - GLP1 5 - SU 6 - DPPIV 7 - Other
2072
Clinical assessment - C-peptide measured nearest graft anniversary (For the first annual assessment please report level measured between 11 and 13 months post transplant) (units: pmol/l)
Format: string up to 4 characters
2073
Clinical assessment - C-peptide measured nearest graft anniversary (For the first annual assessment please report level measured between 11 and 13 months post transplant) - Measured on
Format: DD/MM/YYYY
2074
Clinical assessment - Serum creatinine measured nearest graft anniversary (For the first annual assessment please report level measured between 11 and 13 months post transplant) (units: umol/l, micro-mole per litre)
Format: string up to 4 characters
2075
Clinical assessment - Serum creatinine measured nearest graft anniversary (For the first annual assessment please report level measured between 11 and 13 months post transplant) - Measured on
Format: DD/MM/YYYY
2076
Clinical assessment - Date of Meal Tolerance Test
Format: DD/MM/YYYY
2077
Clinical assessment - Fasting glucose (units: mmol/l)
Format: string up to 3 characters
2078
Clinical assessment - 90-minute glucose (units: mmol/l)
Format: string up to 3 characters
2079
Clinical assessment - Fasting C-peptide (units: pmol/l)
Format: string up to 4 characters
2080
Clinical assessment - 90-minute C-peptide (units: pmol/l)
Format: string up to 4 characters
2081
Clinical assessment - Recipient weight at time of assessment (units: kg)
Format: string up to 4 characters
2082
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Ciclosporin
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2083
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Ciclosporin (If administered) (units: mg/day)
Format: string up to 5 characters
2084
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Tacrolimus
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2085
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Tacrolimus (If administered) (units: mg/day)
Format: string up to 5 characters
2086
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Azathioprine
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2087
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Azathioprine (If administered) (units: mg/day)
Format: string up to 5 characters
2088
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Mycophenolate
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2089
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Mycophenolate (If administered) (units: mg/day)
Format: string up to 5 characters
2090
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Sirolimus/Everolimus
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2091
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Sirolimus/Everolimus (If administered) (units: mg/day)
Format: string up to 5 characters
2092
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Prednisolone/Prednisone
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2093
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Prednisolone/Prednisone (If administered) (units: mg/day)
Format: string up to 5 characters
2094
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Other
Categories: 1 - No 2 - Yes 9 - Unknown If YES futher details will be provided
2095
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Other (If administered) (units: mg/day)
Format: string up to 5 characters
2096
Clinical assessment - Current immunosuppressive drugs at date of assessment (Prior to graft failure for failed grafts, prior to death for deaths with a functioning graft) - Other (If administered)
Text